Obesity: Most Read Stories From 2024
Drug Topics
DECEMBER 31, 2024
Check out this list of our top 5 most read obesity stories from the year 2024.
Drug Topics
DECEMBER 31, 2024
Check out this list of our top 5 most read obesity stories from the year 2024.
Pharmacy Times
DECEMBER 31, 2024
Adding HIV/AIDS to core chronic diseases is a key change.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
DECEMBER 31, 2024
Check out this list of our top 5 most read nonopioid pain management stories from the year 2024.
Pharmacy Times
DECEMBER 31, 2024
The potential treatments include ivermectin, methylene blue, glucagon-like peptide-1 receptor agonists, and low-dose naltrexone.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
DECEMBER 31, 2024
Sangamo is 'surprised and disappointed' by Pfizer's decision to return rights to its gene therapy for haemophilia A after positive phase 3 results
Pharmacy Times
DECEMBER 31, 2024
Bispecific antibodies amivantamab and tarlatamab hold promise for patients.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
DECEMBER 31, 2024
Constantine Tam, MD, discusses zanubrutinib's efficacy in CLL/SLL, emphasizing its durability, high response rates, safety considerations, and evolving therapeutic potential in combination with other agents.
Pharma Marketing Network
DECEMBER 31, 2024
Table of Contents Sr# Headings 1 Introduction: The Pharma Marketing Challenge 2 Building a Winning Pharma Marketing Strategy 3 The Role of Branded Drug Campaigns 4 Innovating for Future Success Introduction: The Pharma Marketing Challenge Marketing pharmaceuticals is no small feat. In an industry where lives are at stake, creating compelling, compliant, and effective campaigns can feel like walking a tightrope.
pharmaphorum
DECEMBER 31, 2024
Phase 3 results with an intrathecal version of Novartis spinal muscular atrophy (SMA) gene therapy could make older children eligible for treatment.
The Checkup by Singlecare
DECEMBER 31, 2024
Prednisone is a medication used to decrease irritation and inflammation in the body. It belongs to a class of drugs called glucocorticoids. There are many different conditions that prednisone is used for, including allergies, asthma, dermatitis, inflammatory bowel disease, arthritis, lymphoma, and leukemia. Its even used for organ transplantation in adults.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
DECEMBER 31, 2024
The AI revolution in pharma and biotech is transforming the healthcare industry. Discover how artificial intelligence is revolutionising drug discovery, precision medicine, and patient care.
The Checkup by Singlecare
DECEMBER 31, 2024
Prednisone is an FDA-approved prescription medication to treat a range of common conditions characterized by inflammation caused by the immune system. It belongs to a class of drugs called corticosteroids (sometimes called glucocorticoids ). Like other steroids, prednisone reduces swelling, redness, and other symptoms caused by immune system reactions.
Blog: Ask a Student Pharmacist
DECEMBER 31, 2024
Frances Abanonu: the power of childhood dreams eomizowh Tue, 12/31/2024 - 12:11 Author: Erin Wilson Third-year PharmD student Frances Abanonu knew at age 11 that she wanted to be a pharmacist. Her early career ambitions stemmed from her father, who was chronically ill and passed away when she was very young. She told herself then that she would grow up to manufacture drugs that would keep others alive.
The Checkup by Singlecare
DECEMBER 31, 2024
Gabapentin is a prescription medication with multiple uses. Its an anticonvulsant often given to people with epilepsy or seizure disorders, but its also a nerve pain medication that helps decrease symptoms of common disorders like shingles and restless legs syndrome as well as treat chronic pain from nerve damage. With so many uses, gabapentin is prescribed frequently by healthcare providersyou may even have a bottle of it in your medicine cabinet right now from a prior illness or injury.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Marketing Network
DECEMBER 31, 2024
Table of Contents Sr# Headings 1 Introduction: The Need for Strategy in Healthcare Marketing 2 Crafting a Patient-Centered Marketing Approach 3 Leveraging Digital Tools for Success 4 Future-Proofing Your Healthcare Marketing Strategy Introduction: The Need for Strategy in Healthcare Marketing Building an effective healthcare marketing strategy can feel like solving a complex puzzle.
The Checkup by Singlecare
DECEMBER 31, 2024
Nurtec ODT (rimegepant) is a brand-name antimigraine drug approved by the Food and Drug Administration (FDA) to treat acute migraines and prevent episodic migraines for adults. Healthcare providers will prescribe this medication to patients who have attempted other types of migraine management or are sensitive to other classes of drugs, such as serotonin-receptor agonists (triptans).
PioneerRx
DECEMBER 31, 2024
As we step into 2025, the pharmacy landscape is evolving rapidly, bringing new opportunities and challenges for independent pharmacies. Staying ahead of these.
The Checkup by Singlecare
DECEMBER 31, 2024
One moment, youre ripping through your to-do list. The next, youre floored by a migraine. Between the pain, sensitivity to light, nausea, and vision disturbances, migraines can derail an entire day and keep you bedridden for hours on end. Thats why Aimovig (erenumab-aooe) comes as such a reassurance. Its the first prescription drug approved by the Food and Drug Administration (FDA) to prevent migraines before they strike, and clinical trials have proven its ability to reduce monthly migraine day
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
DECEMBER 31, 2024
Sangamo said it plans to explore all options to commercialise the asset, including seeking a potential new collaboration partner.
PharmExec
DECEMBER 31, 2024
In this part of his Pharmaceutical Executive video interview, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), talks about advancements in technology and data analysis that could lead to more personalized fertility treatments.
Pharmaceutical Commerce
DECEMBER 31, 2024
Pharma Commerce was on the road extensively throughout 2024, and plenty of insight was gathered along the way.
PharmExec
DECEMBER 31, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
The Checkup by Singlecare
DECEMBER 31, 2024
Metformin and glimepiride are two generic medications that have been approved to treat Type 2 diabetes since 1995. Since Type 2 diabetes is associated with other health risks, such as high blood pressure, heart disease, and stroke, its extremely important for diabetes patients to treat their symptoms and high blood sugar before they become worse. Considering the fact that both of these Type 2 diabetes medications have unique benefits, some people may wonder whether its advisable to take them tog
STAT
DECEMBER 31, 2024
For many of the biggest fish in digital health, 2024 went swimmingly. As the year comes to a close, STAT caught up with leaders from four of the most significant privately-held digital health companies: Omada Health, Transcarent, Hinge Health, and Maven Clinic. Two of them raised “mega rounds” totaling over $100 million each in 2024 and the other two are rumored to be on their way to public offerings next year.
The Checkup by Singlecare
DECEMBER 31, 2024
Quviviq (daridorexant) is a brand-name medication approved by the Food and Drug Administration (FDA) to treat insomnia (difficulty with sleep onset or sleep maintenance) in adults. Quviviq is a medication that is a dual orexin receptor antagonist (DORA)a fancy way of saying that this medication blocks orexin, a substance found in the brain that is involved in wakefulness and arousal, says Brittney Jones, Psy.D., a licensed clinical psychologist, a board-certified insomnia specialist, and founder
STAT
DECEMBER 31, 2024
I think it’s fair to say that everyone expected 2024 to be a little wild, given the U.S. presidential election. But what ended up transpiring this year — particularly when it comes to health, medicine, and the life sciences — became more dramatic than I, at least, had expected: a resurgence of the conversation about vaccines, the shooting of UnitedHealthcare CEO Brian Thompson and the ensuing backlash to the insurance industry, upheaval around weight loss drugs, and so much
The Checkup by Singlecare
DECEMBER 31, 2024
Losartan is a generic medication used to treat a variety of conditions. It is approved by the Food and Drug Administration (FDA) to treat hypertension (high blood pressure) and diabetic nephropathy. It also has several off-label uses (uses not approved by the FDA), such as treating heart failure. Although many people with hypertension take medications like losartan, which is available as brand-name Cozaar, they do come with some common side effects, namely headache, dizziness, and upset stomach.
STAT
DECEMBER 31, 2024
The Food and Drug Administration’s leadership and agenda is about to change, making 2025 a critical year for the agency. With Donald Trump taking office and Robert F. Kennedy Jr. poised to assume the nation’s top health role, it seems the agency is on the precipice of a big shake-up. Kennedy has floated loosening regulation on raw milk, more harshly scrutinizing the safety of vaccines, and cracking down on ultra-processed foods and additives.
Let's personalize your content